DOCTOR DISCUSSION GUIDE

PERSONALIZE YOUR GUIDE

Our goal is for you or your loved one to get the most out of your visit to the doctor. Whether you're just
beginning your treatment journey or looking for another way to treat your chronic rhinosinusitis with nasal
polyposis (CRSwNP), take a moment to answer a few questions. Then use this guide to help start that
conversation with your doctor to see if DUPIXENT may be right for you.

LET’S START
YOUR GUIDE
I'M READY
  • Personal Info
  • Journey
  • Symptom Assessment
  • Impact
  • Review

YOUR PERSONALIZED GUIDE IS READY

We've gathered your answers in a personalized guide that you can save by choosing an option below.
You can save the results of this page for easy referral by adding it to your bookmarks.

Please remember that this is intended to be a helfpul way for you to prepare for your conversation
with your provider but should not replace a full coversation with your provider.

PRINT TO PDF

APPOINTMENT REMINDER

Let’s set an appointment on your calendar to remind you of your next doctor’s visit. It will include a link to your personalized discussion guide for easy reference, which will help you lead a productive conversation with your doctor.

I am a:

PATIENT

CAREGIVER
Time since diagnosis:

TREATMENTS USED

ORAL STEROID USE

Moderate

CRSwNP SEVERITY

Moderate

SYMPTOM FREQUENCY

Nasal congestion:  

Facial
pain/pressure:
  

Fatigue:  

Difficulty
falling asleep:
  

Smell affected

Had surgery

Number of surgeries

TREATMENT GOAL

Indication

DUPIXENT is a prescription medicine used with other medicines for the maintenance treatment of chronic rhinosinusitis with nasal polyposis (CRSwNP) in adults whose disease is not controlled. It is not known if DUPIXENT is safe and effective in children with chronic rhinosinusitis with nasal polyposis under 18 years of age.

Important Safety Information

Do not use if you are allergic to dupilumab or to any of the ingredients in DUPIXENT®.

Please see additional Important Safety Information for DUPIXENT on next page.

SOME QUESTIONS TO ASK YOUR DOCTOR

  • How is DUPIXENT different
    from other treatment options?
  • How does DUPIXENT work?
  • How would I take DUPIXENT?
  • How do I get started with DUPIXENT?
  • What are the possible side effects of DUPIXENT?
  • How can DUPIXENT help treat my uncontrolled CRSwNP?

NOTES

Add any additional notes to discuss with your doctor.

Important Safety Information and Indication

Before using DUPIXENT, tell your healthcare provider about all your medical conditions, including if you:

  • have eye problems.
  • have a parasitic (helminth) infection.
  • are scheduled to receive any vaccinations. You should not receive a “live vaccine” right before and during treatment with DUPIXENT.
  • are pregnant or plan to become pregnant. It is not known whether DUPIXENT will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known whether DUPIXENT passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.

Especially tell your healthcare provider if you are taking oral, topical, or inhaled corticosteroid medicines or if you have CRSwNP and asthma and use an asthma medicine. Do not change or stop your corticosteroid medicine or other asthma medicine without talking to your healthcare provider. This may cause other symptoms that were controlled by the corticosteroid medicine or other asthma medicine to come back.

DUPIXENT can cause serious side effects, including:

  • Allergic reactions. DUPIXENT can cause allergic reactions that can sometimes be severe. Stop using DUPIXENT and tell your healthcare provider or get emergency help right away if you get any of the following signs or symptoms: breathing problems or wheezing, swelling of the face, lips, mouth, tongue, or throat, fainting, dizziness, feeling lightheaded, fast pulse, fever, hives, joint pain, general ill feeling, itching, skin rash, swollen lymph nodes, nausea or vomiting, or cramps in your stomach-area.
  • Eye problems. Tell your healthcare provider if you have any new or worsening eye problems, including eye pain or changes in vision, such as blurred vision. Your healthcare provider may send you to an ophthalmologist for an eye exam if needed.
  • Inflammation of your blood vessels. Rarely, this can happen in people with asthma who receive DUPIXENT. This may happen in people who also take a steroid medicine by mouth that is being stopped or the dose is being lowered. It is not known whether this is caused by DUPIXENT. Tell your healthcare provider right away if you have: rash, chest pain, worsening shortness of breath, or a feeling of pins and needles or numbness of your arms or legs, or persistent fever.
  • Joint aches and pain. Joint aches and pain can happen in people who use DUPIXENT. Some people have had trouble walking or moving due to their joint symptoms, and in some cases needed to be hospitalized. Tell your healthcare provider about any new or worsening joint symptoms. Your healthcare provider may stop DUPIXENT if you develop joint symptoms.

The most common side effects in patients with chronic rhinosinusitis with nasal polyposis include injection site reactions, eye and eyelid inflammation, including redness, swelling, and itching, sometimes with blurred vision, high count of a certain white blood cell (eosinophilia), trouble sleeping (insomnia), toothache, gastritis and joint pain (arthralgia).

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of DUPIXENT. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Use DUPIXENT exactly as prescribed by your healthcare provider. It’s an injection given under the skin (subcutaneous injection). Your healthcare provider will decide if you or your caregiver can inject DUPIXENT. Do not try to prepare and inject DUPIXENT until you or your caregiver have been trained by your healthcare provider.

© 2022 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.
DUPIXENT® and DUPIXENT MyWay® are registered trademarks of Sanofi Biotechnology.
DUP.21.11.0185   Last Update: January 2022